Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients
Journal article published in 2021 by
Jacopo Sabbatinelli,
Angelica Giuliani,
Giulia Matacchione,
Silvia Latini,
Noemi Laprovitera 
,
Giovanni Pomponio,
Alessia Ferrarini,
Silvia Svegliati Baroni,
Marianna Pavani,
Marco Moretti,
Armando Gabrielli,
Antonio Domenico Procopio,
Manuela Ferracin,
Massimiliano Bonafè,
Fabiola Olivieri
,
Giovanni Pomponio,
Alessia Ferrarini,
Silvia Svegliati Baroni,
Marianna Pavani,
Marco Moretti,
Armando Gabrielli,
Antonio Domenico Procopio,
Manuela Ferracin,
Massimiliano Bonafè,
Fabiola Olivieri
